info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Protein Therapeutics Companies

Protein therapeutics companies play a crucial role in the development, manufacturing, and commercialization of therapeutic proteins. These proteins, often derived from living organisms, are used as drugs to treat various diseases and medical conditions. 

Protein Therapeutics Key Companies

 


Latest Protein Therapeutics Companies Update:

Biogen acquires Nightstar Therapeutics Biogen, a leading biotechnology company, acquired Nightstar Therapeutics in December 2023. Nightstar specializes in gene therapy treatments for inherited retinal disorders, expanding Biogen's presence in the gene therapy space with promising protein-based solutions.


Amgen launches biosimilar version of Avastin Amgen, a major player in the protein therapeutics market, launched a biosimilar version of Avastin, a blockbuster cancer drug, in January 2024. This move signals Amgen's focus on expanding its biosimilar offerings and making protein-based treatments more accessible.


Regeneron receives approval for Dupixent in eosinophilic esophagitis Regeneron's Dupixent, a monoclonal antibody, received FDA approval for the treatment of eosinophilic esophagitis in December 2023. This expands the reach of protein therapeutics in addressing previously unmet needs in gastrointestinal disorders.


Sanofi and Alnylam announce positive Phase 3 results for patisiran in hereditary ATTR amyloidosis Sanofi and Alnylam announced positive Phase 3 results for patisiran, a siRNA therapy, in treating hereditary ATTR amyloidosis. This marks a significant advancement in the use of protein therapeutics for rare genetic diseases.


List of Protein Therapeutics Key companies in the market

  • Abbott Laboratories (US)

  • Amgen Inc. (US)

  • Baxter International Inc. (US)

  • Eli Lilly and Company (US)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Johnson & Johnson (US)

  • Merck & Co. Inc. (US)

  • Novo Nordisk A/S (Denmark)

  • CSL Behring (US)

  • Bristol Myers Squibb Co. (US)

  • Pfizer Inc (US)

  • Sanofi (France)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.